Right after last week’s news of a doping matter for U23 Colombian champ Robinson Lopez who resulted positive for the EPO type known by the name of CERA, the UCI announced earlier today that there are seven other professional cyclists that have also tested positive in samples taken during the Vuelta a Colombia on August this year.
The riders who tested positive for Continuous Erythropoietin Receptor Activator aka CERA, which is a third-generation type of the known blood booster called erythropoietin, are now suspended by the UCI.
According to the official press release that UCI gave, it was the cycling “intelligence” that raised suspicions that led to these doping controls. The Cycling Anti-Doping Foundation (CADF) then planned out and managed the testings.
The cyclists who joined Lopez when received an ‘Adverse Analytical Finding’ aka AAF for the type of drug are as follows:
Edward Fabian Diaz Cardenas (EPM)
Jonathan Felipe Paredes Hernandez (Ebsa – Indeportes Boyaca)
Oscar Soliz Vilca (Movistar Amateur Team)
Luis Alberto Largo Quintero (Sogamoso-argos-cooservicios-idrs)
Luis Camargo Flechas (Supergiros)
Fabio Nelson Montenegro Forero (Ebsa – Indeportes Boyaca
While Juan Carlos Cadena Sastoque (Depormundo-m Bosa-ramguiflex) got his AAF for steroid metabolites 19-noretiocholanolone on August 11, 2017.